Participant flow

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss · Source last updated 2025-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Group 1a: New Myeloma; Group 1b: Relapsed Myeloma Group;1c: Smouldering Myeloma Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires

   id

   FG000

   title

   Group 1- Myeloma

2. description

   Baseline AND Follow-Up Assessment: Novel MR Whole body DXA scan Blood and urine samples QOL \& scan experience questionnaires

   id

   FG001

   title

   Group 2- MGUS

3. description

   Baseline Assessment ONLY: * Novel MR * QOL \& scan experience questionnaires

   id

   FG002

   title

   Group 3- Healthy Volunteers

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         9

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         0

      type

      Withdrawal by Subject

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         41

      2. group Id

         FG001

         num Subjects

         14

      3. group Id

         FG002

         num Subjects

         12

      comment

      Enrolment

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         41

      2. group Id

         FG001

         num Subjects

         14

      3. group Id

         FG002

         num Subjects

         12

      comment

      GROUP 1 \& 2 ASSESSMENT * Experimental MR * Whole body DXA scan * Blood and urine samples * QOL \& scan experience questionnaires GROUP 3 ASSESSMENT * Experimental MR * QOL \& scan experience questionnaires

      type

      Baseline Assessment

   3. achievements

      1. group Id

         FG000

         num Subjects

         32

      2. group Id

         FG001

         num Subjects

         12

      3. comment

         Group 3 participants did not attend follow-up

         group Id

         FG002

         num Subjects

         0

      comment

      GROUP 1 \& 2 ASSESSMENT * Experimental MR * Whole body DXA scan * Blood and urine samples * QOL \& scan experience questionnaires GROUP 3 ASSESSMENT • (No follow-up)

      type

      Follow-Up Assessment

   4. achievements

      1. group Id

         FG000

         num Subjects

         32

      2. group Id

         FG001

         num Subjects

         12

      3. group Id

         FG002

         num Subjects

         12

      type

      COMPLETED

   5. achievements

      1. group Id

         FG000

         num Subjects

         9

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Participants from Groups 1 and 2 were identified and approached by a healthcare professional in the oncology clinic at the Churchill Hospital, Oxford. Group 3 participants were typically partners of the participants from Groups 1 and 2 and were recruited at the same time.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice